Nick Pizzie, Chief Financial Officer at Axsome Therapeutics, Inc. (AXSM), bought 10,740 shares at $12.58 ($135K) on 2019-03-19, disclosed to the SEC on 2019-03-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.58 | 5,340 | $67K | 49.7% |
| 2 | $12.58 | 5,340 | $67K | 49.7% |
| 3 | $12.69 | 60 | $761 | 0.6% |
| Total | $12.58 avg | 10,740 | $135K | 100% |
| Filing → |
| AXSM | SELL | 2025-02-14 | $3.5M | — | Filing → |
| AXSM | BUY | 2021-11-22 | $34K | — | Filing → |
| AXSM | BUY | 2020-06-30 | $119K | — | Filing → |